Literature DB >> 32226621

Treating Alcohol Use Disorder in Chronic Liver Disease.

Eric R Yoo1, George Cholankeril2, Aijaz Ahmed2.   

Abstract

http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/15-2-reading-yoo a video presentation of this article http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/15-2-interview-yoo an interview with the author Answer questions and earn https://www.wileyhealthlearning.com/Activity/7036145/disclaimerspopup.aspx.
© 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2020        PMID： 32226621      PMCID： PMC7098671          DOI： 10.1002/cld.881

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  35 in total

1.  High-dose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo-controlled trial.

Authors:  Christian A Müller; Olga Geisel; Patricia Pelz; Verena Higl; Josephine Krüger; Anna Stickel; Anne Beck; Klaus-Dieter Wernecke; Rainer Hellweg; Andreas Heinz
Journal:  Eur Neuropsychopharmacol       Date:  2015-04-14       Impact factor: 4.600

2.  Baclofen for the treatment of alcohol use disorder: the Cagliari Statement.

Authors:  Roberta Agabio; Julia Ma Sinclair; Giovanni Addolorato; Henri-Jean Aubin; Esther M Beraha; Fabio Caputo; Jonathan D Chick; Patrick de La Selle; Nicolas Franchitto; James C Garbutt; Paul S Haber; Mathis Heydtmann; Philippe Jaury; Anne R Lingford-Hughes; Kirsten C Morley; Christian A Müller; Lynn Owens; Adam Pastor; Louise M Paterson; Fanny Pélissier; Benjamin Rolland; Amanda Stafford; Andrew Thompson; Wim van den Brink; Renaud de Beaurepaire; Lorenzo Leggio
Journal:  Lancet Psychiatry       Date:  2018-11-06       Impact factor: 27.083

Review 3.  Prevention and screening, brief intervention, and referral to treatment for substance use in primary care.

Authors:  Stephen Strobbe
Journal:  Prim Care       Date:  2014-03-21       Impact factor: 2.907

Review 4.  Treatment of alcohol use disorders in patients with alcoholic liver disease.

Authors:  Giovanni Addolorato; Antonio Mirijello; Pablo Barrio; Antoni Gual
Journal:  J Hepatol       Date:  2016-05-04       Impact factor: 25.083

5.  A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence.

Authors:  B J Mason; F R Salvato; L D Williams; E C Ritvo; R B Cutler
Journal:  Arch Gen Psychiatry       Date:  1999-08

6.  Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013: Results From the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Bridget F Grant; S Patricia Chou; Tulshi D Saha; Roger P Pickering; Bradley T Kerridge; W June Ruan; Boji Huang; Jeesun Jung; Haitao Zhang; Amy Fan; Deborah S Hasin
Journal:  JAMA Psychiatry       Date:  2017-09-01       Impact factor: 21.596

Review 7.  Gabapentin misuse, abuse and diversion: a systematic review.

Authors:  Rachel V Smith; Jennifer R Havens; Sharon L Walsh
Journal:  Addiction       Date:  2016-03-18       Impact factor: 6.526

8.  Effects of naltrexone on alcohol self-administration and craving: meta-analysis of human laboratory studies.

Authors:  Christian S Hendershot; Jeffrey D Wardell; Andriy V Samokhvalov; Jürgen Rehm
Journal:  Addict Biol       Date:  2016-07-14       Impact factor: 4.280

9.  Baclofen for alcohol use disorder.

Authors:  Silvia Minozzi; Rosella Saulle; Susanne Rösner
Journal:  Cochrane Database Syst Rev       Date:  2018-11-26

10.  Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens.

Authors:  A A Feduccia; J A Simms; D Mill; H Y Yi; S E Bartlett
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.